Hercules PLC
24 July 2026
24 July 2026
Hercules plc
("Hercules" or the "Company")
Change of Auditor
Hercules plc (AIM: HERC), a leading UK infrastructure and construction services group, announces that the Company has undertaken a formal tender process for the role of external auditor.
The Company is pleased to announce the appointment of Cooper Parry Group Ltd as its new auditor, replacing S&W Partners Audit Limited, which has formally resigned and have not notified the Company of any reasons or matters connected with its ceasing to hold office as auditors which it considers should be brought to the attention of shareholders or creditors of the Company.
For further information and enquiries, please contact:
|
Hercules plc Brusk Korkmaz (CEO) Paul Wheatcroft (CFO) |
c/o SEC Newgate |
|
|
|
|
SP Angel (Nominated Adviser and Broker) Matthew Johnson / Adam Cowl (Corporate Finance) Grant Barker / Rob Rees (Sales and Broking) |
+44 (0) 20 3470 0470 |
|
|
|
|
SEC Newgate (Financial Communications) Elisabeth Cowell / Ian Silvera / Darcy Dubell |
+44 (0) 20 3757 6882 Hercules@secnewgate.co.uk |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.